Form 4: CEO John Treace Reports Routine Stock Disposition

Treace Medical Concepts CEO John Treace reported the disposition of 13,219 shares of common stock for tax withholding purposes.

Summary

• John T. Treace, the Chief Executive Officer, Director, and 10% Owner of Treace Medical Concepts, Inc. (TMCI), reported a transaction involving the company's common stock.
• On January 10, 2026, Treace disposed of 13,219 shares of Common Stock.
• This disposition was made to satisfy tax withholding obligations, indicated by transaction code 'F'.
• The shares were disposed of at a price of $0.
• Following this transaction, Treace directly beneficially owns 6,775,887 shares of Common Stock, which includes 363,867 restricted stock units.
• Treace also indirectly beneficially owns shares through his spouse (1,605,000 shares), his spouse as trustee of a trust (1,471,250 shares), as trustee of a trust (1,839,063 shares), and as co-trustee of a trust (408,816 shares).
• The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts where she serves as trustee or co-trustee, and shares held in trusts where he serves as trustee or co-trustee.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a common occurrence and generally does not indicate a change in the company's fundamental performance or the insider's long-term view. Therefore, the sentiment is neutral.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider transaction and does not provide information directly related to broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes.

Key Dates

Keywords

TREACE MEDICAL CONCEPTS, TMCI, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, CEO, John Treace